Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings

Core Insights - Cardinal Health reported better-than-expected second-quarter financial results, with adjusted earnings of $1.93 per share, surpassing market estimates of$1.76 per share, and sales of $55.3 billion, exceeding expectations of$54.915 billion [1][2]. Financial Performance - The company delivered strong second-quarter results, driven by robust demand in the Pharmaceutical and Specialty Solutions segment [2]. - Cardinal Health raised its fiscal year 2025 non-GAAP earnings guidance from a range of $7.75-$7.90 per share to $7.85-$8.00 per share [2]. Stock Performance - Following the earnings announcement, Cardinal Health shares gained 1.3%, trading at $126.92 [3]. - Analysts adjusted their price targets for Cardinal Health, with Wells Fargo raising it from$135 to $136 and JP Morgan increasing it from$142 to $145 [5].